Clinical Trial Update: Intracerebral Autologous Stem Cell Therapy for Chronic Stroke Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intracerebral autologous stem cell therapy for patients with chronic stroke, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Autologous intracerebral stem cell therapy (autologous intracerebral stem cell therapy)

Snippet

Sponsor: Hokkaido University Hospital | Conditions: Stroke, Stroke, Ischemic | Phase 2 | Status: RECRUITING